What is the Impact Factor of Current Neuropharmacology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Current Neuropharmacology is 6.10, ranking in quartile Q1 of Web of Science (SCIE).

Is Current Neuropharmacology indexed in Web of Science or Scopus?

Yes, Current Neuropharmacology is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.642 (Q1) and an H-index of 125.

Who publishes Current Neuropharmacology and what is the Article Processing Charge (APC)?

Current Neuropharmacology is published by Bentham Science Publishers B.V.. The estimated Article Processing Charge (APC) is approximately $3,578 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Current Neuropharmacology?

The official ISO-4 abbreviation of Current Neuropharmacology is "Curr. Neuropharmacol". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #2,068Review JournalHybrid

Current Neuropharmacology

Abbreviation (ISO):Curr. Neuropharmacol

•

Identifier (ISSN):1570-159X(Print)/1875-6190(Online)

•

Publisher:Bentham Science Publishers B.V.

Official Website Submission Portal Compare

Clarivate IF (2026)

6.1↑ +0.8

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Current Neuropharmacology

WoS Q1

Annual Impact Factor Metric

Current (2026):6.1

Scopus SJR & RankScopus Q1

1.642

#2,068

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

125

125 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

139articles/year

6.99% Gold OA•18.12% Original Research

Aims & Scope

Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Topics Covered (Recognized by AI)

Medicine87.4%Biology81.7%Psychology78.2%Internal medicine72.4%Neuroscience71.9%Chemistry59.2%Biochemistry56.5%Genetics54.7%Psychiatry51%Endocrinology43.8%Pathology37.1%Pharmacology36.5%Receptor33.1%Disease25.7%

Primary Research Areas

Medicine Neuroscience

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

NEUROSCIENCES

Rank49/330

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank43/356

IndexSCIE

JCISCIE2026

NEUROSCIENCES

Rank121/330

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank95/356

IndexSCIE

Category	Index	Rank	Quartile
NEUROSCIENCES	JCRSCIE	49/330	Q1
PHARMACOLOGY & PHARMACY	JCRSCIE	43/356	Q1
NEUROSCIENCES	JCISCIE	121/330	Q2
PHARMACOLOGY & PHARMACY	JCISCIE	95/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF6.1

Articles / Year271

Total Citations68

2025

IF5.3

Articles / Year184

Total Citations628

2024

IF4.8

Articles / Year102

Total Citations841

2023

IF5.3

Articles / Year160

Total Citations2,394

2022

IF7.708

Articles / Year210

Total Citations3,537

Year	Impact Factor	Articles / Year	Total Citations
2026	6.1	271	68
2025	5.3	184	628
2024	4.8	102	841
2023	5.3	160	2,394
2022	7.708	210	3,537
2021	7.363	228	6,302
2020	4.668	143	6,718
2019	4.568	75	4,110
2018	4.068	125	8,495
2017	—	108	9,259
2016	—	146	11,074
2015	—	94	5,313

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,068Scopus Q1SCImago Profile

Scopus Coverage:2004-2026

•

Scopus Broad Areas:MedicineNeurosciencePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.642

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

6.36

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,578 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,318

3-Year Documents481

Citable Documents449

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1

NeurologyQ1

Neurology (clinical)Q1

PharmacologyQ1

Pharmacology (medical)Q1

Psychiatry and Mental HealthQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区NEUROSCIENCES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Neuropharmacology (abbr: Curr. Neuropharmacol, ISSN: 1570-159X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Bentham Science Publishers B.V. in England since 2003. The periodical holds a Journal Impact Factor (JIF) of 6.10, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.642 (Q1), an H-index of 125.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 139 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,578 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.